Hester Biosciences Ltd Share Price
(HESTERBIO)
₹1774.9▲0.34%
as on 04:01PM, 17 Apr 2025
Hester Biosciences Ltd Performance
Day's Low
Day's High
₹1,744.1Day's Price Range₹1,83052 Week's Low
52 Week's High
₹1,242.9552-Week Price Range₹3,379
| Returns % | |
| 1 Month Return | + 26.48 % |
| 3 Month Return | -19.62 % |
| 1 Year Return | + 8.7 % |
| Market Stats | |
| Previous Close | ₹1,768.90 |
| Open | ₹1,770.00 |
| Volume | 19.59K |
| Upper Circuit | ₹2,122.60 |
| Lower Circuit | ₹1,415.20 |
| Market Cap | ₹1,509.88Cr |
Hester Biosciences Ltd Fundamentals
P/E Ratio
44.83
PEG Ratio
2.89
Market Cap
₹1,509.88 Cr
P/B Ratio
3.78
EPS
24.88
Dividend Yield
0.43
Sector
Pharmaceuticals
ROE
8.98
Mutual Fund Holdings of Hester Biosciences Ltd
| Funds | Holdings | Prev. 6M |
|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct Growth | 0.04% |
Hester Biosciences Ltd Share analysis
Excluding Excise Duty and Other Income, represents Net Revenue
Hester Biosciences Ltd revenue growth forecast
Expected growth rate Q1, FY2023:0.94%
Forecast
Actual
Including amortisation and stock based compensations
Hester Biosciences Ltd EPS growth forecast
EPS estimate Q1, FY2023:13.74%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Hester Biosciences Ltd
Hester Biosciences Reports Mixed Financial Results - 31 Jan, 2025
Hester Biosciences reported a 5.62% decline in net sales to Rs 63.22 crore for December 2024, while net profit surged 192.72% to Rs 11.66 crore. EBITDA increased by 15.43%, and EPS rose significantly. However, shares have seen a -32.40% return over the last six months.Hester Biosciences Reports Mixed Q3 Financial Results - 30 Jan, 2025
Hester Biosciences reported a significant increase in net profit for Q3 2024-25, driven by foreign exchange gains, despite a decline in revenue and net sales. The company aims to enhance performance with the upcoming Avian Influenza vaccine launch.
Insights on Hester Biosciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 0.59% to 0.87% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, 3.98 Cr → 11.66 Cr (in ₹), with an average increase of 23.5% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, HESTERBIO stock has moved up by 25.7%
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 128.1% return, outperforming this stock by 162.5%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 52.1% return, outperforming this stock by 42.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.73% of holdings in Mar 2025 quarter
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 86.49 Cr → 72.0 Cr (in ₹), with an average decrease of 16.8% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 45.65% to 45.38% in Mar 2025 quarter
Hester Biosciences Ltd Financials
Hester Biosciences Ltd Index Inclusions
Hester Biosciences Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.73% | 0.00 | |
| Foreign Institutions | 0.87% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 45.38% | 0.00 | |
| Others | 0.02% | 0.00 |
Hester Biosciences Ltd Key Indicators
Hester Biosciences Ltd Valuation
Hester Biosciences Ltd in the last 5 years
Lowest (19.52x)
March 23, 2020
Today (44.83x)
April 17, 2025
Industry (53.02x)
April 17, 2025
Highest (124.52x)
July 26, 2024
Hester Biosciences Ltd Earnings and Dividends
Hester Biosciences Ltd Earnings Results
Hester Biosciences Ltd’s net profit jumped 192.96% since last year same period to ₹11.66Cr in the Q3 2024-2025. On a quarterly growth basis, Hester Biosciences Ltd has generated 42.2% jump in its net profits since last 3-months.
Read More about Earnings ResultsHester Biosciences Ltd Dividends May,2024
In the quarter ending March 2024, Hester Biosciences Ltd has declared dividend of ₹6 - translating a dividend yield of 0.79%.
Read More about Dividends
Hester Biosciences Ltd Technicals Summary
Bearish
Neutral
Bullish
Hester Biosciences Ltd is currently in a Bullish trading position according to technical analysis indicators.
Hester Biosciences Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,509.88 Cr | 15.78% | 0.69 | ₹21 Cr | ₹304 Cr | |
| NA | ₹472.34 Cr | 27.04% | 0.57 | NA | NA | |
| NA | ₹71.27 Cr | -0.51% | 0.57 | NA | NA | |
| NA | ₹246.55 Cr | 107.53% | 0.66 | ₹5 Cr | ₹155 Cr | |
| NA | ₹177.04 Cr | 53.55% | 0.62 | NA | NA |
About Hester Biosciences Ltd
Revenue: ₹63.22Cr as on December 2024 (Q4 24)
Net Profit: ₹11.41Cr as on December 2024 (Q4 24)
Listing date: 13 Mar, 2015
| Organisation | Hester Biosciences Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Hester Biosciences Ltd
What is Hester Biosciences Ltd price today?
Hester Biosciences Ltd share price today stands at ₹1774.9, Open: ₹1770, Previous Close: ₹1768.9, High: ₹1830, Low: ₹1744.1, 52 Week High: ₹3379, 52 Week Low: ₹1242.95.
How to Buy Hester Biosciences Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Hester Biosciences Ltd shares
What are today's traded volumes of Hester Biosciences Ltd?
Today's traded volume of Hester Biosciences Ltd(HESTERBIO) is 19.59K.
What is today's market capitalisation of Hester Biosciences Ltd?
Today's market capitalisation of Hester Biosciences Ltd(HESTERBIO) is ₹1509.88Cr.
What is the 52 Week High and Low Range of Hester Biosciences Ltd?
How much percentage Hester Biosciences Ltd is down from its 52 Week High?
Hester Biosciences Ltd (HESTERBIO) share price is ₹1774.9. It is down -47.47% from its 52 Week High price of ₹3379
How much percentage Hester Biosciences Ltd is up from its 52 Week low?
Hester Biosciences Ltd (HESTERBIO) share price is ₹1774.9. It is up 42.80% from its 52 Week Low price of ₹1242.95